Zeo ScientifiX (ZEOX) awards options to executives and director
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Zeo ScientifiX, Inc. reported new stock option awards under its 2021 Incentive Stock Plan. On June 10, 2026, the company granted options for 625,000 shares of common stock each to Greyt Ventures LLC, CEO/CFO and director Ian Bothwell, and Chief Medical Officer and director George Shapiro. These options are fully vested, exercisable on a cashless basis for ten years, with an exercise price of $1.67 per share.
The company also granted 625,000 additional “Incentive Options” to each of Greyt Ventures LLC, Bothwell, and Shapiro that vest upon achievement of specified performance milestones and are exercisable on a cashless basis for ten years at $1.67 per share. These Incentive Options are described as antidilutive for any future transaction that issues 10% or more of common stock on a fully diluted basis. In addition, Zeo ScientifiX awarded options for 80,000 shares to non-executive director Chuck Bretz, fully vested at grant, exercisable for five years at $1.67 per share.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Fully vested options per key recipient: 625,000 shares
Incentive Options per key recipient: 625,000 shares
Director options grant: 80,000 shares
+4 more
7 metrics
Fully vested options per key recipient
625,000 shares
Granted June 10, 2026 under 2021 Plan
Incentive Options per key recipient
625,000 shares
Vest on performance milestones under 2021 Plan
Director options grant
80,000 shares
Granted to non-executive director Chuck Bretz
Exercise price
$1.67 per share
Applies to all option grants disclosed
Term of main options
10 years
Fully vested and Incentive Options for key recipients
Term of director options
5 years
Options granted to non-executive director Bretz
Antidilution trigger level
10% of common stock
Future transaction issuance on fully diluted basis
Key Terms
2021 Incentive Stock Plan, cashless basis, Incentive Options, performance milestones, +1 more
5 terms
2021 Incentive Stock Plan financial
"The Company awarded Options under the 2021 Incentive Stock Plan (the “2021 Plan”)"
cashless basis financial
"The Options are fully vested ... and are exercisable on a “cashless basis” for a period of ten (10) years"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
Incentive Options financial
"The Company awarded Options ... to each of Greyt Ventures LLC, Ian Bothwell and George Shapiro (the “Incentive Options”)."
performance milestones financial
"The Incentive Options vest in full upon the achievement of certain performance milestones"
antidilutive financial
"The Incentive Options are antidilutive for any future transaction that provides for the issuance of 10% or more"
FAQ
What stock option grants did Zeo ScientifiX (ZEOX) disclose in this 8-K?
Zeo ScientifiX disclosed multiple stock option grants under its 2021 Plan. Three parties each received 625,000 fully vested options and 625,000 performance-based Incentive Options, while a non-executive director received 80,000 fully vested options, all at a $1.67 exercise price.
Who received Zeo ScientifiX (ZEOX) stock options and in what amounts?
Greyt Ventures LLC, CEO/CFO and director Ian Bothwell, and CMO and director George Shapiro each received 625,000 fully vested options plus 625,000 Incentive Options. Non-executive director Chuck Bretz received options for 80,000 shares of common stock under the 2021 Incentive Stock Plan.
What are the key terms of the Zeo ScientifiX (ZEOX) executive stock options?
The executive-related options carry a $1.67 per share exercise price, are exercisable on a cashless basis, and have ten-year terms. One set is fully vested at grant, while the Incentive Options vest in full upon achieving specified performance milestones under the 2021 Incentive Stock Plan.
How do Zeo ScientifiX (ZEOX) Incentive Options vest for executives and Greyt Ventures?
The Incentive Options granted to Greyt Ventures LLC, Ian Bothwell, and George Shapiro vest in full upon the achievement of certain performance milestones. Once vested, they are exercisable on a cashless basis for ten years from the award date at an exercise price of $1.67 per share.
What does the antidilutive feature of Zeo ScientifiX (ZEOX) Incentive Options mean?
The Incentive Options are described as antidilutive for any future transaction issuing 10% or more of Zeo ScientifiX’s common stock on a fully diluted basis. This means their terms adjust so the holders’ economic position is protected if large future share issuances occur.
What are the terms of Zeo ScientifiX (ZEOX) options granted to director Chuck Bretz?
Non-executive director Chuck Bretz received options for 80,000 shares of common stock. These options are fully vested as of the grant date, exercisable for five years from the award date, and carry an exercise price of $1.67 per share under the 2021 Incentive Stock Plan.